Go Back

Company or ticker...

Immunovant

Immunovant develops antibody therapies for autoimmune diseases driven by harmful antibodies.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

IMVT

6.9B

0.0

n/a

30.38%

Key Facts

M. Cap

PS

PE

YTD

6.9B

0.0

n/a

30.38%

10MA

20MA

50MA

200MA

$IMVT

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

The Fullstack Investor

by Lin

v1.3

Join Now

Join Now

Join Now

Join Now